Blood Glucose

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
1 program
Lactulose crystals 10 gN/A1 trial
Active Trials
NCT02968498Completed24Est. Feb 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Fresenius KabiLactulose crystals 10 g

Clinical Trials (1)

Total enrollment: 24 patients across 1 trials

NCT02968498Fresenius KabiLactulose crystals 10 g

Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers

Start: Nov 2016Est. completion: Feb 201724 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space